glenzocimab (ACT 017) - Acticor Biotech
milvexian (BMS-986177) - BMS, J&J
abelacimab (MAA868) - Anthos Therap
asundexian (BAY 2433334) - Bayer
http://www.ncbi.nlm.nih.gov/pubmed/39675564
 
Geoffrey D Barnes
 
Dec 16, 2024
 
Prev Next